Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: The ohasama study

Hypertension Research

Volumn 31, Issue 12, 2008, Pages 2129-2135

  Terawaki, Hiroyuki ^a   Metoki, Hirohito ^a,b   Nakayama, Masaaki ^a   Ohkubo, Takayoshi ^a   Kikuya, Masahiro ^c   Asayama, Kei ^a   Inoue, Ryusuke ^a   Hoshi, Haruhisa ^d   Ito, Sadayoshi ^a   Imai, Yutaka ^a,c  

^a TOHOKU UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Ohasama Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE CLEARANCE; DIAGNOSTIC VALUE; FEMALE; HOME BLOOD PRESSURE MEASUREMENT; HUMAN; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; PROTEIN URINE LEVEL; PROTEINURIA; SELF EVALUATION; SUSTAINED HYPERTENSION; SUSTAINED NORMAL BLOOD PRESSURE; WHITE COAT HYPERTENSION; BLOOD PRESSURE MONITORING; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; ETHNOLOGY; INCIDENCE; JAPAN; KIDNEY DISEASE; MASS SCREENING; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; JAPAN; KIDNEY DISEASES; MALE; MASS SCREENING; MIDDLE AGED; ODDS RATIO;

EID: 61949333231     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.2129     Document Type: Article

References (27)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
2. Ninomiya T, Kiyohara Y, Kubo M, et al: Chronic kidney disease and cardiovascular disease in a general Japanese population: The Hisayama Study. Kidney Int 2005; 68: 228-236.
3. Nakayama M, Metoki H, Terawaki H, et al: Kidney dysfunction as a risk factor for first symptomatic stroke events in a general Japanese population - the Ohasama study. Nephrol Dial Transplant 2007; 22: 1910-1915.
4. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl): S1-S246.
5. Pickering TG, Davidson K, Gerin W, Schwartz JE: Masked hypertension. Hypertension 2002; 40: 795-796.
6. Bobrie G, Chatellier G, Genes N, et al: Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291: 1342-1349.
7. Ohkubo T, Kikuya M, Metoki H, et al: Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46: 508-515.
8. Imai Y, Satoh H, Nagai K, et al: Characteristics of a community-based distribution of home blood pressure in Ohasama in northern Japan. J Hypertens 1993; 11: 1441-1449.
9. Imai Y, Abe K, Sasaki S, et al: Clinical evaluation of semi-automatic devices for home blood pressure measurement: Comparison between cuff-oscillometric and microphone methods. J Hypertens 1989; 7 983-990.
10. Imai Y, Otsuka K, Kawano Y, et al, on behalf of the Japanese Society of Hypertension: Japanese Society of Hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res 2003; 26: 771-778.
11. Chonan K, Kikuya M, Araki T, et al: Device for the self-measurement of blood pressure that can monitor blood pressure during sleep. Blood Press Monit 2001; 6: 203-205.
12. Association for the Advancement of Medical Instrumentation: American National Standards for Electronic or Automated Sphygmomanometers (ANSI/ AAMI SP 10-1987). Washington DC, Association for the Advancement of Medical Instrumentation, 1987.
13. Chobanian AV, Bakris GL, Black HR, et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572.
14. European Society of Hypertension-European Society of Cardiology Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
15. Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension: Guidelines for the management of hypertension for general practitioners. Hypertens Res 2001; 24 613-634.
16. Verdecchia P, Staessen JA, White WB, Imai Y, O'Brien ET: Properly defining white coat hypertension. Eur Heart J 2002; 23: 106-109.
17. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
18. Takahashi M, Fukuda Y, Iwata S: Fundamental evaluation and efficacy for protein to creatinine ratio by ATLAS kit cartridge PRO12 using automatic urine analyzer Clinitek ATLAS XL. Igaku To Yakugaku 2002; 48 727-735 (in Japanese).
19. Terawaki H, Yoshimura K, Hasegawa T, et al: Oxidative stress is enhanced in correlation with renal dysfunction: Examination with the redox state of albumin. Kidney Int 2004; 66: 1988-1993.
20. Halbesma N, Kuiken DS, Brantsma AH, et al: Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol 2006; 17: 2582-2590.
21. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164 659-663.
22. Waldron JS, Baoku Y. Hartland AJ, Anderson NR, Horton R, Gama R: Urine microalbumin excretion in relation to exercise-induced electrocardiographic myocardial ischemia. Med Sci Monit 2002; 8 CR725-CR727.
23. Irie F, Iso H, Sairenchi T, et al: 'Me relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int 2006; 69: 1264-1271.
24. Zanaad F, Matzinger A, Larche J: Trough/peak ratios of once daily angiotensin converting enzyme inhibitor and calcium antagonist. Am J Hypertens 1996; 9: 633-643.
25. Agarwal R, Andersen MJ: Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int 2006; 69: 406-411.
26. Levey AS, Coresh J, Greene T, et al, Chronic Kidney Disease Epidemiology Collaboration: Using standard serum creatinine values in the modification of diet renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254.
27. Du Bois D, Du Bois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916; 17 863-871.